22 October 2009
Simon Varcoe
simon.varcoe@informa.com
Merck & Co's sales in the third quarter rose by 2% to $6 billion despite three of its five top-selling brands declining in revenue and a 3% hit from unfavourable foreign exchange rates.
The company's top-selling product, the chronic asthma treatment Singulair (montelukast sodium), grew in...
Please Login to read the full article.
RELATED CONTENT
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
